Countdown to the prescription of Pfizer’s Paxlovid antiviral pill by family doctors. In today’s extraordinary meeting, the Technical Scientific Commission (CTS) of AIFA will evaluate and most likely will approve the therapeutic plan of the antiviral Paxlovid: a sort of ‘user manual’ for the family doctor. Adnkronos Salute learns it. The plan will be completed by the prescribing physician to allow adults affected by Covid-19, who do not need supplemental oxygen therapy and who are at high risk of severe disease progression, to have the drug without going to hospital.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.